INTRODUCTION

Features of apoptosis
There are essentially two ways how cells can die, necrosis and apoptosis. Necrosis is characterized by irreversible swelling and lysis of the cell, which usually occurs in response to a damage of rather unphysiological nature. Due to the disruption of the cell membrane, the cellular content is released, resulting in an inflammatory reaction in the neighbouring tissue. In contrast, apoptosis proceeds via an ordered sequence of events that culminates in the suicide of the cell. Hence, apoptosis is also referred to as programmed cell death. Apoptosis is associated with characteristic morphological features which have been studied in great detail (1; see ref. 2 for review). Briefly, cells undergoing apoptosis separate from neighbouring cells and display a characteristic condensation of the nucleus, as well as blebbing of the plasma membranes and formation of the apoptotic bodies containing cell organelles and chromatin fragments. The content of the apoptotic bodies is not released into the environment. Therefore, in contrast to necrosis, apoptosis does not provoke an inflammatory reaction in the surrounding tissue. In vivo, apoptotic cells are rapidly removed by macrophages, possibly through vitronectin receptormediated phagocytosis (3). Thus, it is difficult to demonstrate the presence of apoptosis in vivo, due to the rapid clearance of such cells. Due to the action of endonucleases during the apoptotic process, the cellular DNA is cut into oligonucleosomal fragments of approximately 200 bp in length, and multiples thereof. Upon electrophoresis in an agarose gel and staining with ethidium bromide, the fragmented DNA gives rise to a characteristic "apoptotic DNA ladder" (4). Probably all cells (except erythrocytes and thrombocytes) have the intrinsic capacity to undergo apoptosis. While it has been obvious for a long time that apoptosis plays a central role in fetal development and organogenesis (2), its significance in the immune system has been recognized only in recent years (5). For some time, the term apoptosis has been used for the morphological description of a specific way of cell death (1). Only recently has it been possible to decipher major pathways of the molecular mechanisms of apoptosis. In this regard, Caenorhabditis elegans has been widely studied. However, major breakthroughs in the identification of molecules involved in apoptosis have been made recently in immunological systems. In the following sections, we will review the recent evidence that programmed cell death plays an important role in the regulation of T-cell mediated immune responses. While programmed cell death of T-cells is frequently associated with the above described typical features of apoptosis including low molecular weight DNA fragmentation, there are well-documented instances where DNA fragmentation is dispensable (6, 7). Moreover, the central role of the apoptosis-inducing interaction between the Fas molecule and its corresponding ligand, Fas-Ligand (see below), is beyond any doubt. Nevertheless, there are examples where signal-induced lymphocyte death occurs in the apparent absence of Fas/Fas-Ligand interaction (8-11). We have coined the term activation-induced cell death (AICD) to describe the signal-induced programmed cell death of T-lymphocytes (12). Apoptosis may also be triggered by the lack of stimuli required for survival or lack of growth factors ("death by neglect"), as is the case with hematopoietic precursor cells in the absence of appropriate colonystimulating factors (13) . In this article, we will concentrate on the induction of AICD via the antigenspecific T-cell receptor (TCR) molecule.
Role of death molecules
Apoptosis can be initiated by triggering of cell surface receptors such as Fas (APO-1) with monoclonal antibodies (mAb) or by interaction with its specific ligand (Fas-L, CD154). Fas is a member of the nerve growth factor (NGF)/tumor necrosis factor (TNF) receptor gene family. The mature protein has 319 amino acids (aa) and a calculated molecular weight of 36 kD (14). The Fas molecule consists of an extracellular domain of 157 aa, a hydrophobic transmembrane domain containing 17 aa, and a cytoplasmic tail of 145 aa at its carboxyl terminal (14). The Fas apoptosis signaling domain is contained within a stretch of 68 amino acids in the intracellular part. Fas shares this characteristic "death domain" with the TNF receptor type I (15). Conversely, the natural ligand of the Fas molecule, Fas-L, belongs to the TNF gene family (16, 17) . Figure 1 shows a diagram indicating the schematic structure of the Fas and Fas-L molecules. In addition to Fas-L and TNFα, other recently identified members of the TNF family such as TRAIL (TNFrelated apoptosis-inducing ligand) can trigger apoptosis in susceptible cells (18). The induction of apoptosis via the Fas molecule requires the close proximity of the cytoplasmic tails of several Fas molecules, as it is induced by crosslinking anti-Fas antibodies or by Fas-L in its trimeric form. The Fas apoptosis pathway does not depend on extracellular Ca 2+ (19, 20) and does not require macromolecular synthesis (14, 21-23). Interestingly, cell death displaying all characteristic morphological features of apoptosis can be triggered via Fas in enucleated cells, indicating that apoptosis can proceed in the absence of a nucleus (6). The signaling through Fas involves the activation of an acidic sphingomyelinase (24) giving rise to the generation of ceramide, a complex lipid which induces rapid apoptosis when added in a membrane-permeable form to cell cultures (25). Ceramide mediates Fas-induced apoptosis through the activation of the Ras signaling pathway (26). In turn, the activation of Ras is associated with the rapid and transient synthesis of reactive oxygen intermediates (ROI), pointing to an important role of ROI in Fas-mediated apoptosis (27, 28). In addition, other components of the Fas-dependent death pathway (FADD, RIP) have been identified by searching for proteins that interact with the intracellular death domain of Fas (29, 30). Other potential regulators of Fas-dependent apoptosis include the FAP-1 phosphatase and the serine/threonine kinase FAST (31, 32) . Although it has been reported that the activation of a protein tyrosine kinase is involved in Fas signaling (33), we have established experimental systems where Fasmediated apoptosis clearly proceeds in the absence of detectable tyrosine phosphorylation (34; and Oberg et al., submitted for publication). Following coimmunoprecipitation with anti-Fas mAb, four cell death-associated proteins (CAP; cytotoxicitydependent APO-1-associated proteins) have been identified, which form a death-inducing signaling complex (DISC) (35) . One of the CAP encodes a 55 kDa protein termed FLICE which shares homology to Interleukin-1β-converting enzyme (ICE) -like cysteine proteases (36) ; this molecule has been independently cloned by Boldin et al and has been termed MACH by this group (37) . The cleavage of cellular substrates including poly (ADP-ribose) polymerase (PARP) and by ICE/CED-3 like proteases is a central event in the execution of apoptosis (38) (39) (40) . Accordingly, apoptosis can be inhibited by peptides that act as competitive substrates for ICE-like proteases (38, 40, 41) .
The Fas/Fas-L system plays a major role in the induction and regulation of programmed cell death in T-lymphocytes. A commonly considered scenario proceeds as follows (see Figure 2) . Upon stimulation of activated T-cells via the CD3/TCR complex, Fas-L mRNA and cell surface expression are rapidly upregulated. Fas-L binds to the surfaceexpressed Fas molecule on the same or on neighbouring cells and triggers apoptosis (42) (43) (44) . Since Fas-L is rapidly cleared from the cell surface through the action of matrix metalloproteases (45), both "suicide" and "fratricide" can be initiated (Figure 2 ). Although the role of the Fas/Fas-L system in the induction of T-cell apoptosis is unambiguous, it is evident that other molecules are perhaps equally important. Under certain circumstances, TNFα can act as a mediator of apoptosis in mature Tlymphocytes (46, 47) . The potential role of the recently described TRAIL molecule (18) in T-cell apoptosis has not yet been precisely defined. It is unlikely that all types ofT-cell apoptosis involve the Fas/Fas-L system (8, 9, 11). Fas-independent apoptosis triggered through the cell surface CD2 molecule has been described (10). Moreover, immobilized mAb against the CTLA4 costimulatory molecule has been reported to induce apoptosis in antigen-specific human T-lymphocytes (48). It is unknown whether the Fas system is involved in this case. The possibility that AICD can take place in Tlymphocytes without the involvement of Fas/Fas-L, will be further discussed (see below).
Apoptosis in intrathymic T-cell development
Immature precursor cells lacking CD3/TCR enter the thymus. During intrathymic development, TCR gene rearrangement takes place, and cell surface-expressed heterodimeric TCRs are randomly generated. The vast majority (> 95 %) of developing thymocytes do not leave the thymus, and die by apoptosis. Only a minority of thymocytes is rescued from programmed cell death, due to positive selection of cells expressing TCR molecules of appropriate affinity/avidity for self MHC molecules to allow for the differentiation into mature self More importantly, negative intrathymic T-lymphocyte selection (by apoptosis) seems to develop to a normal extent in Fas-defective lpr or Fas-L-defective gld mice (51, 52). However, there is evidence that the Fas/Fas-L interaction is involved in the modulation of thymocyte apoptosis (53) . In addition, there are synergistic interactions between the Fas molecule and the CD3/TCR complex in the induction of programmed cell death in thymocytes (54) . Immature thymocytes readily undergo apoptosis following treatment with glucocorticoids or anti-CD3 mAb, both in vivo and in vitro (4, [55] [56] [57] . While these stimuli induce apoptosis irrespective of the antigen specificity of the TCR, selective depletion (by apoptosis) of thymocytes expressing specifically reactive TCR can be triggered by exogenous superantigens such as staphylococcus aureus enterotoxins (58) or by endogenous superantigens encoded by e.g. mouse mammary tumor virus (59) . Taken together, there is no doubt that apoptosis is an important physiological process that contributes to the ordered development of the immune system and the developmental shaping of the TCR repertoire. More recent evidence indicates, however, that apoptosis also regulates immune responses of peripheral Tlymphocytes in the mature immune system.
ACTIVATION-INDUCED CELL DEATH (AICD) OF MATURE T-LYMPHOCYTES
AICD can be triggered in activated Tlymphocytes via the CD3/TCR molecular complex and certain other surface molecules involved in T-cell activation such as CD2. Monoclonal anti-CD3/TCR antibodies have been widely used to study AICD in T-cells. It is assumed that this system adequately mimics the activation of T-cells through TCRmediated recognition of antigen, but the strength (and perhaps the quality) of the signal generated by anti-CD3/TCR mAb versus antigenic peptide presented by appropriate MHC molecules may be quite different. Examples of mAb-and antigen-induced AICD of mature T-cells will be discussed in the following sections.
Induction via the CD3/T-cell receptor molecular complex
The heterodimeric αβ (or γδ) TCR molecule is closely associated with the CD3 polypeptide complex on the surface of T-lymphocytes. While the clonally distributed αβ chains of the TCR serve to recognize short antigenic peptides presented by antigen-presenting cells in the context of MHC class I or class II molecules, the signal transduction occurs via the TCR ξ chain and the ε, γ and δ subunits of the CD3 molecule (see ref. 60 for review). Anti-CD3 mAb (as well as anti-TCR mAb) have been shown to exert antigen-like effects on T-cells, and thus stimulate Ca 2+ influx, cytokine synthesis and interleukin-2 (IL-2)-dependent proliferation (61, 62). As mentioned above, anti-CD3/TCR mAb induce apoptosis in immature thymocytes (55) (56) (57) 63 ). However, T-cells at other stages of differentiation are also susceptible to anti-CD3-induced growth arrest, again associated with the induction of programmed cell death. The spontaneous proliferation of transformed T-cells at various stages of differentiation as well as of T-cell hybridomas was inhibited by anti-CD3 mAb, and cell death associated with DNA fragmentation was observed (64-69). More recently, it was realized that the induction of growth arrest and cell death by anti-CD3/TCR mAb was not restricted to immature thymocytes and transformed Tcells, but could be similarly triggered in mature, nontransformed T-lymphocytes. Early studies indicated that such anti-CD3/TCR mAb inhibited the IL-2-driven in vitro proliferation of activated peripheral murine and human T-lymphocytes (70-73). It was confirmed by several groups that cross-linking of the CD3/TCR complex by mAb triggered AICD in these instances (74) (75) (76) . The early observation that anti-CD3/TCR mAb can initiate AICD in normal Tlymphocytes raised a great deal of interest in the question of how AICD might contribute to the regulation of cellular immune responses. Moreover, the molecular mechanisms controlling the induction or prevention of AICD have developed into a scientific topic of utmost interest to immunologists. It is obvious that a precise understanding of the underlying rules is a prerequisite for successful attempts to modulate AICD, e.g. by pharmacological intervention (77) . As would be expected, resting peripheral T-lymphocytes are generally resistant to AICD triggered by anti-CD3/TCR mAb; instead, these cells respond to CD3/TCR signaling by the induction of a proliferative response. Under in vitro culture conditions, it takes seveal days of stimulation before freshly isolated mature peripheral T-cells acquire sensitivity towards AICD (22, 78-80). In response to anti-TCR mAb, AICD is induced both in T-cells expressing the conventional αβ TCR as well as in T-cells expressing the γδ TCR (81). In contrast to resting mature T-cells of adults, neonatal murine T-cells display enhanced sensitivity to AICD and undergo apoptosis in response to primary TCRmediated stimulation (82). The induction of AICD sensitivity of mature T-cells is influenced by several parameters. Surprisingly, the T-cell growth factor IL-2 has been implicated in the priming of mature Tlymphocytes for AICD (83, 84). It was suggested that the role of growth factors in the induction of apoptosis is to drive T-cells into the S phase of the cell cycle where they are sensitive to TCR-triggered AICD (85). In addition to cytokines, the ligation of cell surface molecules can modulate AICD. Thus, cross-linking of the CD4 T-cell antigen by immobilized anti-CD4 mAb or by the Human Immunodeficiency Virus (HIV) envelope protein, gp120, has been shown to prime CD4 + T-lymphocytes for subsequent apoptosis triggered via the CD3/TCR complex (86, 87). This mechanism might contribute to the continuous decline of CD4 T-lymphocytes in HIV-infected individuals. Only a minor fraction of circulating CD4
+ T-cells is actually infected with HIV; it has been suggested that the disappearance of non-infected CD4 T-cells is due to priming by gp120/anti-gp120 immune complexes and subsequent encounter of antigen through the TCR (88, 89). It appears, however, that the role of CD4 in the regulation of AICD is more complex. While crosslinking of the CD4 molecule primes resting T-cells for apoptosis, we have recently observed opposite effects on activated T-lymphocytes. Thus, ligation of CD4 by anti-CD4 mAb or HIV-1 gp120 drastically inhibited subsequent AICD triggered through CD3/TCR, due to the prevention of upregulation of Fas-L (Oberg et al., submitted for publication). Based on these in vitro observations, we would postulate that gp120 present in the serum of HIV-infected individuals might actually inhibit AICD of circulating activated CD4
+ T-cells. Independent of the seemingly different role of the CD4 molecule for the regulation of AICD in resting versus activated T-cells, it is obvious that the sensitivity to AICD is not limited to CD4 + T-cells (90) but is shared by CD8 + T-cells (74) . Importantly, functionally distinct subpopulations of CD4 + T-cells are equally susceptible to anti-CD3-stimulated programmed cell death, independent of their capacity to exert anti-CD3 mAb-mediated redirected lysis of Fc-receptor-positive target cells (90). While the molecular mechanisms underlying the differential outcome of CD3 signaling (proliferative response or AICD) are not precisely understood, mutagenesis of the immunoreceptor tyrosine-based activation motifs (ITAM) that are the principle signaling components revealed a significant role of the TCR ξ chain in the signaling of AICD (91). The conserved 18 amino acid ITAM sequence is found three times in the TCR ξ chain and once each in the CD3 subunits γ, δ and ε. The induction of efficient AICD required the ITAM motifs of the ξ chain, particularly the membrane proximal Z1 ITAM (91). Taken together, there are multiple examples where AICD has been successfully triggered in normal preactivated T-lymphocytes by mAb against CD3 or TCR. In the following sections, we will briefly review the current evidence that AICD can be also initiated by TCR ligands that are naturally encountered by Tlymphocytes.
AICD triggered by superantigens
In contrast to conventional antigens, superantigens need not be processed by antigenpresenting cells. They activate T-cells by directly bridging the MHC class II molecules on antigenpresenting cells with the variable region of the TCR β chain (92). Most superantigens identified to date are bacterial proteins such as the staphylococcus aureus enterotoxins (SE) or products of endogenous or exogenous (retro)viruses. The injection of SEB into BALB/c mice leads to a transient increase in SEBreactive Vβ8-expressing T-cells, followed by selective depletion of these cells, due to the induction of programmed cell death (93). Although not all Vβ8 cells are deleted following the injection of SEB into mice, the treated animals are tolerant to subsequent challenge with SEB (93, 94). In addition to the deletion of SEB-reactive cells due to apoptosis, other mechanisms such as the induction of anergy in the remaining Vβ8 cells contribute to the functional status of tolerance in such mice (95-101). The deletion of Vβ8 + CD4 + T-cells in response to SEB occurs in the absence of CD8 + T-cells, in support of the notion that activated CD4 + T-cells undergo suicide rather than being killed by CD8 + T-cells (102). AICD following exposure to SEB can be modulated by additional signals. In vivo, clonal deletion of Vβ8 + Tcells is significantly increased when mice are injected with hydrocortisone before the application of SEB (103). Under in vitro conditions, the induction of AICD in sensitized lymph node T-cells by restimulation with SEB is inhibited by mAb directed against lymphocyte function-associated antigen-1 (LFA-1) or intercellular adhesion molecule-2 (ICAM-2), indicating that cell interactions mediated through adhesion molecules can play a role in AICD (104).
Like activated murine T-cells, human CD4 and CD8 T-lymphocytes are susceptible to superantigen-induced AICD (105-107). In contrast to murine T-cells, activated human T-cells express MHC class II antigens. Therefore, AICD of cloned human CD4 + T-cells is triggered by SE superantigens in the absence of additional antigen-presenting cells (105). In the presence of antigen-presenting cells, AICD proceeds to a similar extent, but a proliferative response is simultaneously initiated in the fraction of surviving clone cells (105). Again, the induction of AICD by SE superantigens was inhibited by mAb directed against LFA-1 (CD11a/CD18; ref. 106). While the analysis with human lymphocytes is largely restricted to in vitro experimental systems, clonal deletion of SE-reactive human T-lymphocytes also occurs in vivo in the model of SCID mice reconstituted with human fetal liver and thymus (107).
In addition to bacterial superantigens, endogenous or exogenous retroviral superantigens also delete peripheral T-cells expressing the adequate TCR Vβ elements by induction of AICD. Intrathymic deletion of Vβ14-bearing thymocytes occurs in mice transgenic for mouse mammary tumor virus (MMTV) (59) . Upon transfer of lymphocytes expressing endogenous MMTV, or of lymphocytes maternally infected with MMTV, into recipients lacking this retroviral superantigen, deletion of T-cells expressing the reactive TCR Vβ elements occurs in vivo (108, 109). Therefore, superantigens of both bacterial and viral origin are potent inducers of AICD in activated T-lymphocytes from various species.
AICD triggered by conventional antigens
It has been known for some time that specific antigen can inhibit the proliferative response of murine mature T-lymphocytes (110-112). The recognition of the specific antigenic peptide presented by appropriate MHC class I molecules triggers the self-destruction of cytotoxic T-cells, due to the induction of AICD (113-117). In vivo, such a mechanism seems to contribute to the termination of an ongoing cellular immune response. Systemic infection with lymphocytic choriomeningitis virus (LCMV) is accompanied by cellular expansion of virus-specific CD8 + T-cells. Following virus control, the number of CD8 + T-cells decreases, due to the induction of apoptosis (118) . In transgenic mice expressing a transgenic TCR specific for LCMV glycoprotein peptide 33-41, the injection of this peptide induced deletion of transgenic T-cells by AICD (119) . Similarly, the exposure to specific antigen induces peripheral CD8 + T-cell deletion also in other TCR transgenic mice with different TCR specificity, e.g. for the male-specific H-Y antigen (120) (121) (122) + Tlymphocytes, AICD is preferentially triggered by high concentrations of peptide antigen in cytotoxic T-cells displaying high avidity TCR (133) . Similarly, the induction of apoptosis in antigen-specific CD4 T-cells occurs preferentially at high antigen concentrations (134, 135) . Taken together, it appears that antigen dosage is a major factor controlling the induction of AICD in activated mature T-lymphocytes.
Role of Fas/Fas-Ligand interaction in antigeninduced AICD
AICD triggered in transformed T-cells and T-cell hybridomas by stimulation of the CD3/TCR complex is mediated via the induction of Fas-L expression and subsequent interaction of Fas-L with the Fas/CD95 antigen (42) (43) (44) . Similarly, the superantigen-induced AICD of activated normal Tlymphocytes seems to depend on Fas/Fas-L interactions and can be inhibited by reagents that interfere with this interaction, e.g. some anti-Fas mAb or Fas-Fc fusion proteins (42, 136, 137) . Several lines of evidence indicate that the Fas/Fas-L system is also operational in vivo in the course of deletion of peripheral T-lymphocytes. Thus, apoptotic T-cells isolated from the peripheral blood or the draining lymph nodes of mice injected with bacterial superantigen express high levels of Fas and Fas-L (138, 139) . Moreover, lpr mice carrying a genetic defect in the Fas gene (140) are unable to normally delete peripheral T-cells following the injection of bacterial superantigen (138, 141) or conventional peptide antigen (51), and have a defect in AICD triggered in vitro by superantigen or anti-CD3 mAb (141) (142) (143) . There is evidence, however, that AICD can also take place in vivo in the absence of a functional Fas molecule. Thus, it was observed by Tucek-Szabo and coworkers that the injection of high concentrations of anti-CD3 mAb triggered apoptosis to a comparable degree in lymph node T-cells from wild-type and lpr mice (144) . In addition, the in vivo elimination of male-antigen (H-Y)-specific T-cells occurs normally when lymph node cells from female H-Y TCR transgenic lpr/lpr mice are injected into B6 nu/nu male mice (145) . Moreover, the peripheral CD4 + T-cell deletion following the injection of influenza hemagglutinin into TCR transgenic mice was similar in mice of normal or Fas defective lpr background (47). In the latter case, the peripheral deletion of transgenic T-cells following the in vivo administration of the specific antigenic peptide was prevented by a neutralizing anti-TNFα mAb (47), suggesting that TNFα might be involved as an effector molecule in AICD of mature T-lymphocytes (46, 47) . Despite the clear-cut evidence for the important role of the Fas/Fas-L system in AICD triggered via the CD3/TCR complex, it is obvious that, at least under certain conditions, AICD can proceed in the absence of a functional Fas molecule. It is conceivable that TNFα, the related TRAIL molecule (18), or other ligand-receptor interactions might transduce death signals in these situations.
CLINICAL IMPLICATIONS
The elimination of potentially self-reactive thymocytes during intrathymic T-cell development involves apoptotic mechanisms. The above summarized observations indicating that antigen can also trigger AICD in mature peripheral Tlymphocytes suggest that programmed cell death also plays a role in the establishment of peripheral tolerance (12). Moreover, the intentional induction of AICD might form the basis for novel immunotherapeutical strategies.
Role of AICD in peripheral tolerance
While it is clear that programmed cell death is the major mechanism of the intrathymic elimination of self-reactive lymphocytes, it is less obvious that apoptotic deletion contributes to the establishment of tolerance to foreign antigens in the peripheral immune system. The establishment and maintenance of peripheral tolerance is a multi-step process that may involve functional "anergy" (146, 147), downmodulation of cell surface TCR expression (147) , as well as physical elimination of antigenreactive T-cells (93, 149, 150; see ref. 151 for review). In the setting of allograft transplantation, it is highly desirable to induce tolerance in the transplant recipient towards donor MHC and non-MHC antigens. Pearson and coworkers reported that brief treatment of C3H/He recipient mice with anti-CD4 mAb together with C57/BL10 donor cells induced specific tolerance of subsequent C57/BL10 cardiac allografts (152) . It is possible (although not proven in this study) that CD4 cross-linking primed the recipient T-cells for AICD following TCRmediated recognition of donor alloantigens, in accordance with the in vitro studies (86). In support of this possibility, it was reported by Markmann and coworkers that the clonal deletion of antigen-reactive T-cells following the intrathymic inoculation with Mls-disparate lymphoid cells required the additional application of anti-CD4 mAb (153) . In experimental models of organ transplantation, the intrathymic injection of donor lymphoid cells has been successfully used to prolong cardiac and liver allograft survival, possibly through the induction of AICD in alloreactive T-cells (154, 155) . Furthermore, some immunosuppressive drugs that are used in clinical transplantatiom medicine might in part exert their effect through the modulation of AICD. While cyclosporin A (CsA) and FK506 inhibit AICD triggered through CD3 or CD2 in vitro (156, 157) , both drugs can actually enhance apoptosis of immature thymocytes in vivo (158, 159) . Interestingly, FK506 but not CsA, also augmented superantigen-induced AICD of peripheral Tlymphocytes following the injection of SEB into mice (159) . Such a mechanism might contribute to the clinical efficacy of FK506. Finally, it is noteworthy that the clinically used anti-CD3 mAb is a potent inducer of in vitro AICD in activated human Tlymphocytes (76) . Therefore, AICD might contribute to the immunosuppressive effect of anti-CD3 treatment, in addition to other mechanisms such as modulation of cell surface CD3 expression.
Recent studies suggest that the Fas/Fas-L system also plays a role in the prevention of graft rejection. Bellgrau and coworkers reported that testicular allografts expressing Fas-L escaped rejection by inducing apoptosis in Fas-expressing recipient T-cells activated by graft antigens (160) . It should be noted, however, that the expression of Fas-L might not always be beneficial for graft survival. In contrast to Bellgrau et al. (160) , Yagita and coworkers observed a severe inflammatory rejection of Fas-L expressing baby hamster kidney (BHK) fibroblasts, apparently mediated by neutrophils (161) . Nevertheless, it appears that the constitutive expression of Fas-L forms the basis for the maintenance of immunological tolerance in so-called "immune privileged sites" such as the anterior chamber of the eye (162).
Therapeutical perspectives in autoimmune diseases
The discovery that antigen can delete antigen-reactive mature T-lymphocytes through the induction of AICD has raised great interest in the potential clinical application of this approach in the treatment of certain autoimmune diseases. A widely studied model of T-cell mediated autoimmune disease is experimental autoimmune encephalomyelitis (EAE). The injection of the relevant autoantigen, myelin basic protein (MBP), or the transfer of MBPspecific T-cells, triggers EAE in susceptible rats and mice. In situ, apoptotic T-cells can be detected in the central nervous system of Lewis rats suffering from EAE (163) . During the spontaneous recovery from EAE, antigen-specific down-regulation of MBPreactive T-cells occurs, due to the selective apoptotic elimination of autoreactive T-lymphocytes from the target organ (164, 165) . These results suggest the possibility that the application of specific (auto)antigen may be used to delete unwanted autoreactive T-cells by the induction of AICD. In fact, several experimental autoimmune diseases can be prevented by the injection of large doses of the relevant autoantigen (166, 167) . Although it was not reported in these studies whether apoptosis was involved in the induction of tolerance, there are welldocumented examples that high doses of autoantigen can delete autoreactive T-cells via AICD. Critchfield and coworkers induced EAE in mice by the adoptive transfer of MBP peptide-reactive T-cells. In contrast to mice injected with a control antigen, mice injected with the relevant MBP peptide had a dramatic deletion of T-cells expressing the MBP-reactive TCR, and did not develop disease (168) . Peripheral deletion of antigen-reactive T-lymphocytes can also be achieved by other routes of antigen application. In the studies of Chen and coworkers, the oral application of high concentrations of ovalbumin triggered the deletion of antigen-reactive T-cells in the Peyer's patches of mice transgenic for the ovalbumin-specific TCR (169) . Thus, the deletion of antigen-reactive T-cells via the induction of AICD is a promising new approach in the treatment of autoimmune and certain other diseases (170, 171) . However, in contrast to experimental models, the relevant autoantigen in human disease is frequently unknown, and antigen-independent strategies of modulation of AICD and apoptosis need to be pursued.
Concluding remarks
It is obvious that the induction or prevention of AICD in peripheral T-lymphocytes is a complex process that is regulated by multiple signals, only some of which have been discussed here. Depending on the experimental system, AICD is modulated by cytokines (46, (83) (84) (85) (172) (173) (174) (175) and costimulatory signals (141, 176) . In this review, we have focussed on AICD of peripheral T-cells triggered through signaling via the CD3/TCR complex. There are other clinically important situations where a disturbance of apoptosis is suspected to contribute to the pathogenesis of the disease. Several reviews have recently discussed the possible role of apoptosis in the progressive loss of CD4 + T-cells during HIV infection (e.g., ref. 177). Therefore, this aspect has not been discussed here. Moreover, there is increasing evidence that apoptosis is an important parameter contributing to the regulation of the interaction between tumor cells and the immune system. It is obvious that a defective capacity to undergo physiological programmed cell death could form the basis for uncontrolled growth of tumor cells. Perhaps more importantly, tumors may also actively prevent T-cells from cell-mediated tumor cell attack through the exploration of the Fas/Fas-L system. This hypothesis is supported by the recent demonstration that some tumor cells constitutively express the Fas-L, thus inducing apoptosis in tumor-infiltrating Fas + T-lymphocytes (178, 179) . This may be an important mechanism of immune escape of tumor cells. In conclusion, there are various lines of evidence that antigen-induced cell death contributes to the regulation of cellular immune responses as well as to the establishment of peripheral immune tolerance. The continued elucidation of the molecular mechanisms involved in the control of AICD will hopefully provide exciting perspectives for the treatment of certain diseases. 
